Class Action Lawsuit
-
Ultragenyx Pharmaceutical Class Action Lawsuit: April 6, 2026 Deadline to File Claims – Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC
Ultragenyx Pharmaceutical Inc. faces a class action lawsuit with an April 6, 2026 deadline for claimants. The suit involves allegations regarding the company’s business practices and disclosures, common in the pharmaceutical sector due to complex regulations and market dynamics. Affected parties should consult legal counsel specializing in class action litigation and securities law to understand their rights and ensure timely filing.
-
Coupang, Inc. Class Action Lawsuit Filing Deadline: February 17, 2026 – Contact Lewis Kahn, Esq. of Kahn Swick & Foti, LLC
Coupang faces a potential class-action lawsuit deadline on February 17, 2026. Investors who believe they were misled regarding the e-commerce giant’s financial health, operations, or growth strategies are encouraged to seek legal counsel. Allegations may stem from misrepresentations about aggressive investments, profitability, and the scalability of its advanced logistics and technology systems. This situation highlights the risks associated with rapid expansion in the tech sector.
-
Jayud Global Logistics Ltd. Class Action Lawsuit: January 20, 2026 Application Deadline – Contact Lewis Kahn, Esq.
Jayud Global Logistics faces a securities fraud class action lawsuit for alleged “pump-and-dump” activities between April 2023 and April 2025. Investors must act by January 20, 2026, to be considered for lead plaintiff. Despite recent strategic acquisitions and expansion announcements, the company’s stock has underperformed, and market reactions to operational news appear muted amidst ongoing legal challenges.
-
Jayud Global Logistics Ltd. Class Action Lawsuit: Apply by January 19, 2026. Contact Lewis Kahn, Esq.
Jayud Global Logistics faces a securities fraud lawsuit alleging a “pump-and-dump” scheme and stock manipulation via social media misinformation. Investors who traded between April 21, 2023, and April 30, 2025, have until January 19, 2026, to join the class action. The suit claims the company misled investors about its business prospects by failing to disclose deceptive practices.
